Term ends Jan 10, 2027 · High confidence
20-year base term ends Jan 10, 2027
Held by Alcon Inc.
Filed Dec 21, 2012 as application 13/723,811 · Granted Dec 30, 2014
Base term, 20 years from filing
Today
2007
2027
Clock starts
Jan 10, 2007
Jan 10, 2007
Term ends
Jan 10, 2027
Jan 10, 2027
Granted
Dec 30, 2014
Dec 30, 2014
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 10, 2007, when application 11/621,887, the earliest non-provisional in its chain, was filed (this one was filed Dec 21, 2012) | Jan 10, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 10, 2027 | High confidence |
This family
| US 7,470,787 | Term ended Aug 2026 | Aug 2026 |
| US 8,455,513 | Lapsed on the fee record Jun 2025 | Jun 2025 |
| US 7,671,205 | Term ended Jul 2026 | Jul 2026 |
| Application PCT/US2008/050374 | PCT application no patent term | no patent term |
| US 8,034,943 | Term ended Jul 2026 | Jul 2026 |
| US 8,357,699 | Term ended Jul 2026 | Jul 2026 |
| US 8,455,647 | Term ended Jul 2026 | Jul 2026 |
| US 8,921,392 | this patent Jan 2027 | Jan 2027 |
8 of 12 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 19, 2013 Reel 29832, frame 455 | Delong, Mitchell A.; Royalty, Susan M.; Sturdivant, Jill Marie; Heintzelman, Geoffrey Richard | Aerie Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Sep 11, 2014 Reel 33726, frame 43 | Aerie Pharmaceuticals, Inc. | Deerfield Management Company, L.P., as Agent; Deerfield Partners, L.p.; Deerfield International Master Fund, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Special Situations International Master Fund, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Management Company, L.P., as Agent | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Partners, L.p. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield International Master Fund, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Private Design Fund III, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Special Situations Fund, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Special Situations International Master Fund, L.P. | Security Interest |
| Jul 23, 2018 Reel 46431, frame 500 | Deerfield Partners, L.p.; Deerfield Private Design Fund III, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Management Company, L.p. | Aerie Distribution, Inc. | Release of Security Interest |
| Jul 23, 2018 Reel 46431, frame 600 | Deerfield Partners, L.p.; Deerfield Private Design Fund III, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Management Company, L.p. | Aerie Pharmaceuticals, Inc. | Release of Security Interest |
| Jul 23, 2018 Reel 46432, frame 307 | Aerie Pharmaceuticals, Inc. | Deerfield Private Design Fund III, L.P. | Security Interest |
| Sep 5, 2019 Reel 50276, frame 807 | Deerfield Private Design Fund III, L.P. | Aerie Pharmaceuticals, Inc. | Release of Security Interest |
| Jun 24, 2024 Reel 67822, frame 168 | Aerie Pharmaceuticals, Inc. | Alcon Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2027
Term ends Jan 10, 2027.
Citations
67
later US patents cite this one
That is top 10% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.